Monthly Archives: November 2017

Thursday 30th november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Des chercheurs de l’université de Copenhague révèlent que l’un des composés sulfurés de l’ail pourrait être utilisé contre les bactéries résistantes chez […]

Posted in Synthèse de presse | Comments closed

Pancreatic Cancer: a “Multiomic” Study Identified Two Tumor Subtypes, and a Potential New Treatment Avenue

Juan Iovanna (Inserm Research Director) and his colleagues at the Marseille Cancer Research Center (Inserm/CNRS/Aix Marseille Université/Institut Paoli-Calmettes), in close collaboration with the “Tumor identity cards (CIT)” program run by the Ligue nationale contre le cancer and the University of Wisconsin (United States), have generated a “bank” of approximately 200 viable human pancreatic tumors, and cells derived from these tumors. The “multiomic” analysis of these tumors, i.e. the general characterization of all alterations in gene expression, epigenetic modifications of DNA methylation, has evidenced two main tumor subtypes. The specific characteristics of these subtypes, identified by the researchers, could open up new therapeutic approaches. The results of this research have been published in the journal Cell Reports.

Posted in Cancer, Press releases | Tagged | Comments closed

Wednesday 29th november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Après des mois de tractations, l’américain Merck (MSD en France) a trouvé un accord sur le montant du remboursement de son traitement […]

Posted in Synthèse de presse | Comments closed

Tuesday 28th november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Lefigaro.fr rapporte que « des champignons cueillis en région parisienne ont permis de « guérir » des cellules de personnes atteintes de mucoviscidose ». Le champignon […]

Posted in Synthèse de presse | Comments closed

Monday 27th november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Des chercheurs de l’université de Southampton, qui ont analysé les données provenant de plus de 200 études, affirment que boire du café […]

Posted in Synthèse de presse | Comments closed

An Edible Mushroom With Potential to Fight Human Genetic Diseases

Could a common mushroom help fight certain genetic diseases? Although surprising, this is indeed the new discovery made by French scientists from Inserm, the French National Museum of Natural History, the CNRS, Université de Lille, and the Institut Pasteur de Lille[1]. By examining numerous extracts, the scientists thus evidenced that the mushroom, Lepista inversa, acted significantly on three isolated cell lines taken from patients with cystic fibrosis. This research was published in .Plos One

Posted in Cell biology, development and evolution, Press releases | Tagged | Comments closed

Friday 24th november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Le service de Maurice Mimoun, à l’hôpital Saint-Louis à Paris, a réussi à sauver un homme, dont le corps était brûlé à […]

Posted in Synthèse de presse | Comments closed

Thursday 23rd november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Les cinquièmes rencontres des maladies rares se sont déroulées à Paris les 20 et 21 novembre, indique Le Figaro. Les chercheurs et […]

Posted in Synthèse de presse | Comments closed

Ribosome Plasticity: a New Avenue in Targeted Cancer Therapy

The “Nuclear Domains and Pathologies” team led by Jean-Jacques Diaz, Inserm Research Director at the Cancer Research Center of Lyon (Inserm/CNRS/Université Claude Bernard Lyon 1/Centre Léon Bérard), has recently demonstrated that one of the essential components of the “cellular machinery” that produces proteins – the ribosome – is altered in tumors. The researchers have observed that these modified ribosomes function differently in cancer cells, preferentially producing proteins that favor cancer cell proliferation and survival.  This discovery opens up new possibilities for the development of innovative cancer therapies that target this abnormal machinery. This research has been published in Proceedings of the National Academy of Sciences (PNAS).

Posted in Cancer, Press releases | Tagged | Comments closed

Wednesday 22nd november 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. « Les résultats des travaux réalisés sur la cohorte NutriNet-Santé portent à croire que la viande rouge influence les risques de cancer au […]

Posted in Synthèse de presse | Comments closed
fermer
fermer
RSS Youtube